These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26258293)

  • 41. Repeating pattern of non-RVD variations in DNA-binding modules enhances TALEN activity.
    Sakuma T; Ochiai H; Kaneko T; Mashimo T; Tokumasu D; Sakane Y; Suzuki K; Miyamoto T; Sakamoto N; Matsuura S; Yamamoto T
    Sci Rep; 2013 Nov; 3():3379. PubMed ID: 24287550
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The position of DNA cleavage by TALENs and cell synchronization influences the frequency of gene editing directed by single-stranded oligonucleotides.
    Rivera-Torres N; Strouse B; Bialk P; Niamat RA; Kmiec EB
    PLoS One; 2014; 9(5):e96483. PubMed ID: 24788536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TALE: a tale of genome editing.
    Zhang M; Wang F; Li S; Wang Y; Bai Y; Xu X
    Prog Biophys Mol Biol; 2014 Jan; 114(1):25-32. PubMed ID: 24291598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Zinc finger nucleases: custom-designed molecular scissors for genome engineering of plant and mammalian cells.
    Durai S; Mani M; Kandavelou K; Wu J; Porteus MH; Chandrasegaran S
    Nucleic Acids Res; 2005; 33(18):5978-90. PubMed ID: 16251401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tailor-made TALEN system for highly efficient targeted gene replacement in the rice blast fungus.
    Arazoe T; Ogawa T; Miyoshi K; Yamato T; Ohsato S; Sakuma T; Yamamoto T; Arie T; Kuwata S
    Biotechnol Bioeng; 2015 Jul; 112(7):1335-42. PubMed ID: 25683503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficient genome engineering by targeted homologous recombination in mouse embryos using transcription activator-like effector nucleases.
    Sommer D; Peters A; Wirtz T; Mai M; Ackermann J; Thabet Y; Schmidt J; Weighardt H; Wunderlich FT; Degen J; Schultze JL; Beyer M
    Nat Commun; 2014; 5():3045. PubMed ID: 24413636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genome editing with engineered nucleases in plants.
    Osakabe Y; Osakabe K
    Plant Cell Physiol; 2015 Mar; 56(3):389-400. PubMed ID: 25416289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeted gene disruption in the Xenopus tropicalis genome using designed TALE nucleases.
    Nakajima K; Nakai Y; Okada M; Yaoita Y
    Zoolog Sci; 2013 Jun; 30(6):455-60. PubMed ID: 23721469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assembly of custom TALE-type DNA binding domains by modular cloning.
    Morbitzer R; Elsaesser J; Hausner J; Lahaye T
    Nucleic Acids Res; 2011 Jul; 39(13):5790-9. PubMed ID: 21421566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficient production of a gene mutant cell line through integrating TALENs and high-throughput cell cloning.
    Sun C; Fan Y; Li J; Wang G; Zhang H; Xi JJ
    J Lab Autom; 2015 Feb; 20(1):46-50. PubMed ID: 25524489
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new strategy for the in vitro selection of stapled peptide inhibitors by mRNA display.
    Iqbal ES; Richardson SL; Abrigo NA; Dods KK; Osorio Franco HE; Gerrish HS; Kotapati HK; Morgan IM; Masterson DS; Hartman MCT
    Chem Commun (Camb); 2019 Aug; 55(61):8959-8962. PubMed ID: 31290487
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advances in directed protein evolution by recursive genetic recombination: applications to therapeutic proteins.
    Kurtzman AL; Govindarajan S; Vahle K; Jones JT; Heinrichs V; Patten PA
    Curr Opin Biotechnol; 2001 Aug; 12(4):361-70. PubMed ID: 11551464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Directed Evolution Empowered Redesign of Natural Proteins for the Sustainable Production of Chemicals and Pharmaceuticals.
    Bornscheuer UT; Hauer B; Jaeger KE; Schwaneberg U
    Angew Chem Int Ed Engl; 2019 Jan; 58(1):36-40. PubMed ID: 30520553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimization of protein therapeutics by directed evolution.
    Vasserot AP; Dickinson CD; Tang Y; Huse WD; Manchester KS; Watkins JD
    Drug Discov Today; 2003 Feb; 8(3):118-26. PubMed ID: 12568781
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phage display: protein engineering by directed evolution.
    O'Neil KT; Hoess RH
    Curr Opin Struct Biol; 1995 Aug; 5(4):443-9. PubMed ID: 8528759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tools for TAL effector design and target prediction.
    Booher NJ; Bogdanove AJ
    Methods; 2014 Sep; 69(2):121-7. PubMed ID: 24981075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TALENoffer: genome-wide TALEN off-target prediction.
    Grau J; Boch J; Posch S
    Bioinformatics; 2013 Nov; 29(22):2931-2. PubMed ID: 23995255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systematic molecular evolution enables robust biomolecule discovery.
    DeBenedictis EA; Chory EJ; Gretton DW; Wang B; Golas S; Esvelt KM
    Nat Methods; 2022 Jan; 19(1):55-64. PubMed ID: 34969982
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phage-assisted continuous and non-continuous evolution.
    Miller SM; Wang T; Liu DR
    Nat Protoc; 2020 Dec; 15(12):4101-4127. PubMed ID: 33199872
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Protein engineering: from directed evolution to computational design].
    Qu G; Zhu T; Jiang Y; Wu B; Sun Z
    Sheng Wu Gong Cheng Xue Bao; 2019 Oct; 35(10):1843-1856. PubMed ID: 31668033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.